• Enamine Ltd., of Kiev, Ukraine, signed a collaboration agreement with the Medical Research Council Laboratory of Molecular Biology (MRC LMB) in Cambridge, UK, and the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic (IOCB) in Prague, Czech Republic, to discover rhomboid protease inhibitors as potential drugs to treat infectious, parasitic, oncological, immune and cardiovascular diseases.